Aura Biosciences, Inc.
AURA
$6.51
$0.213.33%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -0.05% | 0.69% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.47% | -1.45% | |||
| Operating Income | 2.47% | 1.45% | |||
| Income Before Tax | 3.21% | 1.80% | |||
| Income Tax Expenses | -45.83% | 166.67% | |||
| Earnings from Continuing Operations | 3.29% | 1.69% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 3.29% | 1.69% | |||
| EBIT | 2.47% | 1.45% | |||
| EBITDA | 2.47% | 1.45% | |||
| EPS Basic | 14.90% | 15.06% | |||
| Normalized Basic EPS | 14.87% | 15.13% | |||
| EPS Diluted | 14.90% | 15.06% | |||
| Normalized Diluted EPS | 14.87% | 15.13% | |||
| Average Basic Shares Outstanding | 13.65% | 15.74% | |||
| Average Diluted Shares Outstanding | 13.65% | 15.74% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||